Enliven Therapeutics
Price & Volume
Stats
See more52W Range | $14.78-$48.53 |
Market Cap | $2.6B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.64 |
News
See moreYahoo Finance • 3 days ago
Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120%
Yahoo Finance • 6 days ago
Why is Enliven Therapeutics (ELVN) One of the Best Performing Healthcare Stocks so Far in 2026?
Yahoo Finance • 29 days ago
Enliven Therapeutics (ELVN) Up 194% This Year on Strong CML Market
Yahoo Finance • last month
Enliven (ELVN) Gets Higher Price Targets From H.C. Wainwright and Mizuho
About
CEO | Mr. Richard A. Fair M.B.A. |
CFO | Mr. Benjamin Hohl |
Address | 6200 Lookout Road, Boulder, CO, United States, 80301 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 61 |